LALAURA LOGAN-THOMAS: Open Payments
NPI 1598438095 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $513 · 2025 $711
Food & beverage: $599Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $180 |
| Axsome Therapeutics, Inc. | 3 | $168 |
| Teva Pharmaceuticals USA, Inc. | 2 | $126 |
| ABBVIE INC. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: Auvelity, LYBALVI, VRAYLAR, CAPLYTA, ARISTADA, ABILIFY MAINTENA, COBENFY, INVEGA SUSTENNA.
Industry payments across IA — which companies pay providers there.
